The 9 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 18.00, with a high estimate of 40.00 and a low estimate of 12.00. The median estimate represents a +200.00% increase from the last price of 6.00.
The current consensus among 10 polled investment analysts is to Buy stock in Viking Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.21
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.